Beurs gesloten -
Nasdaq
22:00:00 31-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
57,79
USD
|
+0,86%
|
|
+0,84%
|
-7,96%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
18.808
|
19.048
|
16.213
|
17.869
|
14.072
|
12.994
|
-
|
-
|
Bedrijfswaarde
1 |
16.742
|
17.535
|
13.865
|
14.630
|
10.416
|
9.163
|
7.589
|
6.096
|
K/w-verhouding
|
42,6
x
|
-64
x
|
17,2
x
|
52,8
x
|
23,7
x
|
17,8
x
|
14,4
x
|
11,1
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
8,71
x
|
7,14
x
|
5,43
x
|
5,26
x
|
3,81
x
|
3,18
x
|
2,88
x
|
2,6
x
|
Bedrijfswaarde/omzet
|
7,76
x
|
6,58
x
|
4,64
x
|
4,31
x
|
2,82
x
|
2,24
x
|
1,68
x
|
1,22
x
|
Bedrijfswaarde/EBITDA
|
36,7
x
|
-82,8
x
|
21,5
x
|
24,5
x
|
14,8
x
|
9,68
x
|
5,77
x
|
3,5
x
|
Bedrijfswaarde/FCF
|
26,5
x
|
-56,2
x
|
24,4
x
|
16,4
x
|
22,4
x
|
10,2
x
|
7,11
x
|
4,59
x
|
FCF Yield
|
3,78%
|
-1,78%
|
4,1%
|
6,1%
|
4,45%
|
9,76%
|
14,1%
|
21,8%
|
Price to Book
|
7,22
x
|
7,26
x
|
4,32
x
|
4,09
x
|
2,71
x
|
2,27
x
|
1,82
x
|
1,49
x
|
Aantal aandelen (in duizenden)
|
215.397
|
218.996
|
220.891
|
222.475
|
224.109
|
224.855
|
-
|
-
|
Referentieprijs
2 |
87,32
|
86,98
|
73,40
|
80,32
|
62,79
|
57,79
|
57,79
|
57,79
|
Datum van publicatie
|
13/02/20
|
9/02/21
|
8/02/22
|
7/02/23
|
13/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
2.159
|
2.667
|
2.986
|
3.395
|
3.696
|
4.085
|
4.515
|
5.001
|
EBITDA
1 |
456,5
|
-211,9
|
643,6
|
597,7
|
703,2
|
946,4
|
1.316
|
1.740
|
Bedrijfsresultaat (EBIT)
1 |
402
|
-263,7
|
585,8
|
579,4
|
620,5
|
1.051
|
1.341
|
1.662
|
Operationele Marge
|
18,62%
|
-9,89%
|
19,62%
|
17,07%
|
16,79%
|
25,73%
|
29,69%
|
33,23%
|
Resultaat voor belastingen (EBT)
1 |
486,8
|
-232,2
|
570,4
|
529,1
|
834,2
|
975,4
|
1.284
|
1.700
|
Nettowinst (verlies)
1 |
446,9
|
-295,7
|
948,6
|
340,7
|
597,6
|
758,6
|
962,6
|
1.216
|
Nettomarge
|
20,7%
|
-11,09%
|
31,76%
|
10,04%
|
16,17%
|
18,57%
|
21,32%
|
24,31%
|
WPA
2 |
2,050
|
-1,360
|
4,270
|
1,520
|
2,650
|
3,240
|
4,019
|
5,227
|
Free Cash Flow
1 |
632,6
|
-312
|
568,5
|
892,1
|
464
|
894,3
|
1.067
|
1.329
|
FCF-marge
|
29,3%
|
-11,7%
|
19,04%
|
26,28%
|
12,56%
|
21,89%
|
23,64%
|
26,58%
|
Kasstroomconversie (ebitda)
|
138,56%
|
-
|
88,33%
|
149,27%
|
65,99%
|
94,49%
|
81,1%
|
76,41%
|
Kasstroomconversie (nettowinst)
|
141,55%
|
-
|
59,93%
|
261,88%
|
77,64%
|
117,89%
|
110,87%
|
109,35%
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
13/02/20
|
9/02/21
|
8/02/22
|
7/02/23
|
13/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Omzet
1 |
862,9
|
733,2
|
911,4
|
823,3
|
926,7
|
808,7
|
954,6
|
919
|
1.013
|
880,9
|
1.010
|
1.052
|
1.130
|
1.003
|
1.142
|
EBITDA
|
125,6
|
-
|
270,9
|
155,1
|
137,9
|
-
|
214,1
|
236,1
|
-
|
113,8
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
110,7
|
116,5
|
254,4
|
138,4
|
70,09
|
24,77
|
193,8
|
214,7
|
187,3
|
91,9
|
263,5
|
289,1
|
332,2
|
335,3
|
406
|
Operationele Marge
|
12,83%
|
15,89%
|
27,92%
|
16,81%
|
7,56%
|
3,06%
|
20,3%
|
23,36%
|
18,48%
|
10,43%
|
26,09%
|
27,48%
|
29,39%
|
33,43%
|
35,55%
|
Resultaat voor belastingen (EBT)
1 |
120
|
70,54
|
229,4
|
148,6
|
80,62
|
51,86
|
277,6
|
233,8
|
271
|
236,2
|
259,3
|
116,7
|
364
|
231,5
|
337,8
|
Nettowinst (verlies)
1 |
563,9
|
37,99
|
161,4
|
112,8
|
28,46
|
21,7
|
203,5
|
171,3
|
201,1
|
169,5
|
189,2
|
125,7
|
267,9
|
189,8
|
277
|
Nettomarge
|
65,35%
|
5,18%
|
17,71%
|
13,7%
|
3,07%
|
2,68%
|
21,32%
|
18,64%
|
19,84%
|
19,25%
|
18,73%
|
11,95%
|
23,7%
|
18,92%
|
24,26%
|
WPA
2 |
2,540
|
0,1700
|
0,7200
|
0,5000
|
0,1300
|
0,1000
|
0,9000
|
0,7600
|
0,8900
|
0,7500
|
0,8154
|
0,6573
|
1,060
|
0,8400
|
1,220
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
8/02/22
|
3/05/22
|
2/08/22
|
1/11/22
|
7/02/23
|
2/05/23
|
1/08/23
|
31/10/23
|
13/02/24
|
30/04/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
2.067
|
1.513
|
2.348
|
3.239
|
3.656
|
3.831
|
5.405
|
6.898
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
633
|
-312
|
568
|
892
|
464
|
894
|
1.067
|
1.329
|
ROE (netto-inkomsten/eigen vermogen)
|
27,2%
|
-11,4%
|
29,7%
|
8,37%
|
12,5%
|
15,9%
|
17,6%
|
18%
|
ROA (netto-inkomsten/totale activa)
|
20,3%
|
-8,46%
|
22,3%
|
6,32%
|
9,47%
|
12,3%
|
14%
|
14,2%
|
Totale activa
1 |
2.205
|
3.494
|
4.247
|
5.387
|
6.312
|
6.160
|
6.883
|
8.563
|
Nettoactief per aandeel
2 |
12,10
|
12,00
|
17,00
|
19,60
|
23,10
|
25,50
|
31,80
|
38,80
|
Cashflow per aandeel
2 |
3,270
|
-0,5700
|
3,370
|
4,330
|
2,200
|
4,330
|
5,140
|
6,910
|
Capex
1 |
78,1
|
187
|
181
|
77,8
|
32,5
|
38,7
|
118
|
152
|
Capex/omzet
|
3,62%
|
7,03%
|
6,06%
|
2,29%
|
0,88%
|
0,95%
|
2,61%
|
3,04%
|
Datum van publicatie
|
13/02/20
|
9/02/21
|
8/02/22
|
7/02/23
|
13/02/24
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
57,79
USD Gemiddelde koersdoel
72,8
USD Spread / Gemiddelde doel +25,97% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -7,96% | 12,99 mld. | | -2,29% | 89,87 mld. | | -3,95% | 37,57 mld. | | +63,05% | 26,47 mld. | | -22,14% | 14,25 mld. | | -9,33% | 11,93 mld. | | -46,33% | 10,84 mld. | | +5,77% | 9,11 mld. | | -17,66% | 7,32 mld. | | +88,73% | 7,14 mld. |
Biofarmaceutica
|